For 2025, Eurofins anticipates mid-single-digit organic growth, driven by recovery in biopharma and agrosciences, though growth in the first half may remain subdued. The company highlighted its ...

Eurofins is Testing for Life ... and in the support of clinical studies, as well as in biopharma contract development and manufacturing. It also has a rapidly developing presence in highly ...

Eurofins Scientific SE ... and labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications ...